These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15116089)

  • 21. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.
    Zhou Q; Stetler-Stevenson M; Steeg PS
    Oncogene; 1997 Jul; 15(1):107-15. PubMed ID: 9233783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation.
    Koziczak M; Hynes NE
    J Biol Chem; 2004 Nov; 279(48):50004-11. PubMed ID: 15377668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt interaction with PLC(gamma) regulates the G(2)/M transition triggered by FGF receptors from MDA-MB-231 breast cancer cells.
    Browaeys-Poly E; Perdereau D; Lescuyer A; Burnol AF; Cailliau K
    Anticancer Res; 2009 Dec; 29(12):4965-9. PubMed ID: 20044603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
    Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
    Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defects in G1-S cell cycle control in head and neck cancer: a review.
    Michalides RJ; van de Brekel M; Balm F
    Head Neck; 2002 Jul; 24(7):694-704. PubMed ID: 12112544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro.
    Lwin ZM; Yip GW; Chew FT; Bay BH
    Anat Rec (Hoboken); 2012 Mar; 295(3):410-6. PubMed ID: 22266712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
    Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
    J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential for targeting the fibroblast growth factor receptors in breast cancer.
    Hynes NE; Dey JH
    Cancer Res; 2010 Jul; 70(13):5199-202. PubMed ID: 20570901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.
    Zhang Q; Sakamoto K; Wagner KU
    Mol Cell Endocrinol; 2014 Jan; 382(1):583-592. PubMed ID: 23562856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of FGFR inhibitors on chicken limb development.
    Horakova D; Cela P; Krejci P; Balek L; Moravcova Balkova S; Matalova E; Buchtova M
    Dev Growth Differ; 2014 Oct; 56(8):555-72. PubMed ID: 25280231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
    Ye L; Guo L; He Z; Wang X; Lin C; Zhang X; Wu S; Bao Y; Yang Q; Song L; Lin H
    Oncotarget; 2016 Apr; 7(17):23757-71. PubMed ID: 26992224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.
    Loilome W; Joshi AD; ap Rhys CM; Piccirillo S; Vescovi AL; Gallia GL; Riggins GJ
    J Neurooncol; 2009 Sep; 94(3):359-66. PubMed ID: 19340397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential role of AKT in tumor cells addicted to FGFR.
    Hu Y; Lu H; Zhang J; Chen J; Chai Z; Zhang J
    Anticancer Drugs; 2014 Feb; 25(2):183-8. PubMed ID: 24100276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced sequential expression of G1/S cyclins during experimental epatocarcinogenesis and tyrosine phosphorylation.
    Sundarrajan M; Fernandis AZ; Subrahmanyam G; Prabhudesai S; Krishnamurthy SC; Rao KV
    J Environ Pathol Toxicol Oncol; 2001; 20(3):189-97. PubMed ID: 11797828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of G1 arrest and differentiation in MDA-MB-231 breast cancer cell by boehmeriasin A, a novel compound from plant.
    Yan J; Luo D; Luo Y; Gao X; Zhang G
    Int J Gynecol Cancer; 2006; 16(1):165-70. PubMed ID: 16445628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
    Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
    Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
    André F; Cortés J
    Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer.
    Yiangou C; Cox H; Bansal GS; Coope R; Gomm JJ; Barnard R; Walters J; Groome N; Shousha S; Coombes RC; Johnston CL
    Br J Cancer; 1997; 76(11):1419-27. PubMed ID: 9400937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclins and breast cancer.
    Musgrove EA; Hui R; Sweeney KJ; Watts CK; Sutherland RL
    J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):153-62. PubMed ID: 10887489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.